149 related articles for article (PubMed ID: 6785242)
1. Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Volleberg MP; Lemmens PJ; van Boven CP
Infect Immun; 1981 Mar; 31(3):896-905. PubMed ID: 6785242
[TBL] [Abstract][Full Text] [Related]
2. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; van Boven CP
Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
[TBL] [Abstract][Full Text] [Related]
3. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
[TBL] [Abstract][Full Text] [Related]
4. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
Gonggrijp R; Mullers WJ; van Boven CP
Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
[TBL] [Abstract][Full Text] [Related]
5. Ribonuclease-sensitive ribosomal vaccines.
Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
8. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
Phillips M; Rimler RB
Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
Lieberman MM; McKissock DC; Wright GL
Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
[TBL] [Abstract][Full Text] [Related]
10. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
Hatano K; Goldberg JB; Pier GB
Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
[TBL] [Abstract][Full Text] [Related]
11. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.
Pier GB; Koles NL; Meluleni G; Hatano K; Pollack M
Infect Immun; 1994 Apr; 62(4):1137-43. PubMed ID: 8132318
[TBL] [Abstract][Full Text] [Related]
12. RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.
Antonissen AC; Lemmens PJ; Gonggrijp R; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1985; 51(2):227-40. PubMed ID: 2412492
[TBL] [Abstract][Full Text] [Related]
13. Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.
MacIntyre S; Lucken R; Owen P
Infect Immun; 1986 Apr; 52(1):76-84. PubMed ID: 3082762
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides.
Lang AB; Fürer E; Larrick JW; Cryz SJ
Infect Immun; 1989 Dec; 57(12):3851-5. PubMed ID: 2509371
[TBL] [Abstract][Full Text] [Related]
15. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.
Hatano K; Goldberg JB; Pier GB
J Bacteriol; 1993 Aug; 175(16):5117-28. PubMed ID: 7688717
[TBL] [Abstract][Full Text] [Related]
17. Opsonic activity of antisera to ribosomal vaccine fractions with live and formalinized Pseudomonas aeruginosa.
Lieberman MM; Allen RC
Can J Microbiol; 1986 Jun; 32(6):531-3. PubMed ID: 3089571
[TBL] [Abstract][Full Text] [Related]
18. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N
J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis.
Lam JS; Mutharia LM; Hancock RE; Høiby N; Lam K; Baek L; Costerton JW
Infect Immun; 1983 Oct; 42(1):88-98. PubMed ID: 6194119
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.
Phillips M; Eisenstein TK; Meissler J
Infect Immun; 1985 Apr; 48(1):244-7. PubMed ID: 3980087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
